February 2015

Actinium Pharmaceuticals Prices Offering Of 4.4 Million SharesInvestor NewswireActinium Pharmaceuticals (ATNM), a biopharmaceutical company developing immunotherapeutics for the treatment of advanced cancers, has priced an underwritten public offering of an aggregate 4.4 million shares of common stock and warrants to purchase … and more …read more

Actinium Announces Pricing of Public Offering of Common Stock and Warrants to …StockhouseThe shares of common stock and warrants will be issued separately. The warrants will be exercisable for a period of 4 years following the issuance thereof at an exercise price of $6.50 per share. The warrants will be certificated, and will be delivered

Actinium Announces Pricing of Public Offering of Common Stock and Warrants to …Business Wire (press release)The shares of common stock and warrants will be issued separately. The warrants will be exercisable for a period of 4 years following the issuance thereof at an exercise price of $6.50 per share. The warrants will be certificated, and

Actinium Announces Proposed Public Offering of Common Stock and Warrants …StockhouseThe Company expects to grant the underwriters a 30-day option to purchase up to an additional 15 percent (15%) of the number of shares of common stock and warrants sold in the offering solely to cover over-allotments, if any. The offering is subject to …

Actinium Announces Proposed Public Offering of Common Stock and Warrants …Marketwired (press release)The Company expects to grant the underwriters a 30-day option to purchase up to an additional 15 percent (15%) of the number of shares of common stock and warrants sold in the offering solely to cover over-allotments, if any. The offering is subject